December 16, 2017 - By Michael Collier
Symphony Asset Management Llc decreased its stake in Xilinx Inc Com (XLNX) by 59.41% based on its latest 2017Q2 regulatory filing with the SEC. Symphony Asset Management Llc sold 18,244 shares as the company’s stock rose 11.01% with the market. The institutional investor held 12,463 shares of the technology company at the end of 2017Q2, valued at $801,000, down from 30,707 at the end of the previous reported quarter. Symphony Asset Management Llc who had been investing in Xilinx Inc Com for a number of months, seems to be less bullish one the $17.06 billion market cap company. The stock decreased 0.13% or $0.09 during the last trading session, reaching $67.98. About 4.31 million shares traded or 118.68% up from the average. Xilinx, Inc. (NASDAQ:XLNX) has risen 52.08% since December 16, 2016 and is uptrending. It has outperformed by 35.38% the S&P500.
Pinnacle Wealth Management Advisory Group Llc increased its stake in Walt Disney Co (DIS) by 76.71% based on its latest 2017Q2 regulatory filing with the SEC. Pinnacle Wealth Management Advisory Group Llc bought 3,376 shares as the company’s stock declined 2.31% while stock markets rallied. The institutional investor held 7,777 shares of the television services company at the end of 2017Q2, valued at $826,000, up from 4,401 at the end of the previous reported quarter. Pinnacle Wealth Management Advisory Group Llc who had been investing in Walt Disney Co for a number of months, seems to be bullish on the $167.06 billion market cap company. The stock increased 2.79% or $3 during the last trading session, reaching $110.61. About 15.95M shares traded or 102.89% up from the average. The Walt Disney Company (NYSE:DIS) has risen 9.26% since December 16, 2016 and is uptrending. It has underperformed by 7.44% the S&P500.
Investors sentiment increased to 1.04 in 2017 Q2. Its up 0.18, from 0.86 in 2017Q1. It is positive, as 38 investors sold XLNX shares while 193 reduced holdings. 75 funds opened positions while 165 raised stakes. 236.47 million shares or 4.26% more from 226.81 million shares in 2017Q1 were reported. Next Grp holds 0% of its portfolio in Xilinx, Inc. (NASDAQ:XLNX) for 222 shares. Northwestern Mutual Wealth has invested 0% in Xilinx, Inc. (NASDAQ:XLNX). 332 are held by Thompson Davis &. Page Arthur B reported 1.81% stake. Capital Investment Counsel has invested 0.29% in Xilinx, Inc. (NASDAQ:XLNX). Gradient Invs Ltd Company invested in 5 shares or 0% of the stock. Kansas-based Waddell Reed has invested 0.07% in Xilinx, Inc. (NASDAQ:XLNX). Citigroup Inc has 218,753 shares. Cohen Lawrence B owns 14,716 shares for 0.61% of their portfolio. Tahithromos Lc reported 80,000 shares. The North Carolina-based Bb&T has invested 0.03% in Xilinx, Inc. (NASDAQ:XLNX). Rafferty Asset Mgmt Limited Liability Company has invested 0.23% in Xilinx, Inc. (NASDAQ:XLNX). Fil Ltd reported 0.46% in Xilinx, Inc. (NASDAQ:XLNX). Maverick Cap Ltd reported 59,510 shares. Argent Capital Ltd Liability Company reported 0.02% stake.
Among 23 analysts covering Xilinx Inc. (NASDAQ:XLNX), 7 have Buy rating, 2 Sell and 14 Hold. Therefore 30% are positive. Xilinx Inc. had 55 analyst reports since July 24, 2015 according to SRatingsIntel. On Wednesday, November 15 the stock rating was maintained by KeyBanc Capital Markets with “Buy”. As per Tuesday, July 18, the company rating was upgraded by Barclays Capital. KeyBanc Capital Markets maintained it with “Buy” rating and $70.0 target in Wednesday, September 6 report. The stock of Xilinx, Inc. (NASDAQ:XLNX) earned “Buy” rating by Jefferies on Thursday, August 31. The stock has “Reduce” rating by Nomura on Tuesday, January 3. Barclays Capital downgraded Xilinx, Inc. (NASDAQ:XLNX) rating on Wednesday, January 18. Barclays Capital has “Underweight” rating and $53 target. On Thursday, October 15 the stock rating was maintained by FBR Capital with “Mkt Perform”. On Wednesday, July 26 the stock rating was maintained by Rosenblatt with “Hold”. Morgan Stanley maintained the stock with “Overweight” rating in Wednesday, December 13 report. The stock of Xilinx, Inc. (NASDAQ:XLNX) earned “Overweight” rating by Morgan Stanley on Thursday, December 15.
Since August 3, 2017, it had 0 insider purchases, and 5 insider sales for $15.35 million activity. $754,957 worth of Xilinx, Inc. (NASDAQ:XLNX) was sold by Hover-Smoot Scott.
Analysts await Xilinx, Inc. (NASDAQ:XLNX) to report earnings on January, 24. They expect $0.63 earnings per share, up 21.15% or $0.11 from last year’s $0.52 per share. XLNX’s profit will be $158.10 million for 26.98 P/E if the $0.63 EPS becomes a reality. After $0.65 actual earnings per share reported by Xilinx, Inc. for the previous quarter, Wall Street now forecasts -3.08% negative EPS growth.
Symphony Asset Management Llc, which manages about $16.99B and $886.38M US Long portfolio, upped its stake in Thermo Fisher Scientific Inc (NYSE:TMO) by 4,759 shares to 19,700 shares, valued at $3.44M in 2017Q2, according to the filing. It also increased its holding in Jazz Investments I Ltd (Prn) by 4.85 million shares in the quarter, for a total of 8.18 million shares, and has risen its stake in Merck & Company (NYSE:MRK).
Pinnacle Wealth Management Advisory Group Llc, which manages about $161.62M US Long portfolio, decreased its stake in Vanguard Large Cap Etf (VV) by 5,295 shares to 26,255 shares, valued at $2.92M in 2017Q2, according to the filing.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.